<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU>

<div class=WordSection1>

<h1><span lang=EN-US style='font-size:15.0pt;line-height:107%'>2017B12 Describe
the clinical effects of non-steroidal anti-inflammatory drugs <br>
including mechanisms through which they exert these effects.</span></h1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>List:</span></h3>

<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Classification and examples</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Arachidonic acid pathway</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Prostaglanding receptors</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>The big 3 effects</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Organ system effects</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>COX-2 selective</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>NSAID
classification: (examiner request)</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=170 valign=top style='width:127.2pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Non-selective irreversible</span></p>
  </td>
  <td width=425 valign=top style='width:318.95pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Salicylates: aspirin</span></p>
  </td>
 </tr>
 <tr>
  <td width=170 valign=top style='width:127.2pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Non-selective reversible</span></p>
  </td>
  <td width=425 valign=top style='width:318.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Propioinic
  acids (e.g. ibuprofen, naproxen)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Phenylacetic
  acid derivative (e.g. diclofenac)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Indoles
  (e.g. indomethacin)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Enolic
  acid derivatives (e.g. meloxicam)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>(many
  others)</span></p>
  </td>
 </tr>
 <tr>
  <td width=170 valign=top style='width:127.2pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>COX-2 selective</span></p>
  </td>
  <td width=425 valign=top style='width:318.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Celecoxib</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Parecoxib
  (pro-drug for valdecoxib)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.2pt;margin-bottom:.0001pt;text-indent:-8.2pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Rofecoxib
  (no longer in use)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Arachidonic acid
pathway:</span></h3>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US><img width=466 height=328 id="Picture 3"
src="2017B12_nsaids_files/image001.jpg"></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Prostaglandin
receptors: </span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=138 valign=top style='width:103.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>G protein coupled receptor subtypes</span></p>
  </td>
  <td width=463 valign=top style='width:347.55pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>G<sub>s</sub>:
  ↑cAMP</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>G<sub>i</sub>:
  ↓cAMP</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>G<sub>q</sub>:
  ↑IP<sub>3</sub> -&gt; ↑ICF [Ca<sup>2+</sup>], ↑DAG</span></p>
  </td>
 </tr>
 <tr>
  <td width=138 valign=top style='width:103.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Prostaglandin receptor subtypes</span></p>
  </td>
  <td width=463 valign=top style='width:347.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>PGD2:
  G<sub>s</sub>, G<sub>i</sub></span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>PGE2:
  G<sub>q</sub>, G<sub>s</sub></span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>PGF<sub>2</sub></span><sub><span
  lang=EN-US>α</span></sub><span lang=EN-US>: G<sub>q</sub></span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>PGI<sub>2</sub>:
  G<sub>i</sub></span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>TXA<sub>2</sub>:
  G<sub>q</sub>, G<sub>s</sub></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>The big three:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Anti-pyretic</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>↓PGE<sub>2</sub> in hypothalamus</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Analgesic</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PG
  (especially E<sub>2</sub>) production at inflamed tissue </span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Nociceptive
  receptor activation and expression</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Hyperalgaesia
  and allodynia</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Anti-inflammatory</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PG
  (especially E<sub>2</sub>) production by inflamed tissues</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Vasodilatation,
  ↓capillary leak, ↓oedema, ↓WBC chemotaxis</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Healing:
  bone (post fracture), pleura (post pleurodesis)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Organ systems:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Cardiovascular</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGI<sub>2</sub>
  -&gt; vasoconstriction, ↑platelet aggregation -&gt; thrombosis e.g. AMI<br>
  (especially COX-2 inhibitors; rofecoxib withdrawn for this reason)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓TXA<sub>2</sub>
  -&gt; vasodilatation, ↓platelet aggregation -&gt; bleeding, bruising</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Risk
  of systemic vasculitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Respiratory</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGD<sub>2</sub>
  -&gt; bronchodilatation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGE<sub>2</sub>
  -&gt; bronchoconstriction</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGF<sub>2</sub></span><sub><span
  lang=EN-US>α</span></sub><span lang=EN-US> -&gt; bronchodilatation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↑Shunt
  of arachidonic acid to leukotrienes -&gt; bronchoconstriction</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>(overall:
  bronchoconstriction, ↑in 20% asthmatics)</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Gastro-intestinal</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGE<sub>2</sub>
  -&gt; ↑parietal cell activity -&gt; ↑HCl secretion</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Deranged
  LFT</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Renal</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGE<sub>2</sub>,
  ↓PGI<sub>2</sub> -&gt; ↓tubuloglomerular feedback, ↓renin release</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:34.9pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Risk of
  renal failure, hyperkalaemia</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:34.9pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Important
  if hypovolaemic or also taking ACE inhibitor</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Ureteric
  contraction -&gt; pass kidney stone (indomethacin)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Risk
  interstitial nephritis</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Obstetric</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGE<sub>2</sub>
  -&gt; myometrial relaxation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGF<sub>2</sub></span><sub><span
  lang=EN-US>α</span></sub><span lang=EN-US> -&gt; myometrial relaxation</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓PGE<sub>2</sub>
  -&gt; closure of ductus arteriosus -&gt; asphyxia</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Other</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Displace
  other drugs from protein-binding sites, e.g. warfarin on albumin</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Metabolic
  acidosis in overdose</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>COX-2
inhibitors:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Pros</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Selective
  for inflamed tissue (enzyme is inducible cf. constitutive)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Peptic
  ulceration</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Bronchoconstriction</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Renal
  impairment (examiner 2013)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↓Bleeding
  risk</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Cons</span></p>
  </td>
  <td width=505 valign=top style='width:379.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↑Thrombosis
  risk, AMI (rofecoxib)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↑Fluid
  retention</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Expensive</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Sulfur
  allergy</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.05pt;margin-bottom:.0001pt;text-indent:-8.05pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Parecoxib
  is a prodrug with very slow onset of effect</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
